U.S. Markets closed

Pacira Pharmaceuticals, Inc. (PCRX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
45.4500-0.85 (-1.84%)
At close: 4:00PM EDT

45.4941 0.04 (0.10%)
After hours: 4:32PM EDT

People also watch
SUPNPTLAIRWDCLVSPBYI
Interactive chart
Previous Close46.3000
Open46.5000
Bid0.0000 x
Ask48.2000 x 100
Day's Range45.0965 - 46.6000
52 Week Range29.9500 - 58.9500
Volume543,178
Avg. Volume929,583
Market Cap1.82B
Beta2.24
PE Ratio (TTM)-31.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Pacira Pharmaceuticals, Inc. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacira Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PCRX-US. Comparing the performance and risk of Pacira Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
    Capital Cube7 days ago

    Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Pacira Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pacira Pharmaceuticals, Inc. – DURECT Corporation, Acura Pharmaceuticals, Inc., Recro Pharma, Inc., Heron Therapeutics Inc, BioDelivery Sciences International, Inc., Cara Therapeutics Inc, Flexion Therapeutics, Inc., Cumberland Pharmaceuticals Inc., ... Read more (Read more...)

  • Paul Tudor Jones' Top 4 Health Care Buys
    GuruFocus.com7 days ago

    Paul Tudor Jones' Top 4 Health Care Buys

    Guru invested in multiple health care stocks in 1st quarter